文献速递前列腺癌

机器人辅助经会阴MRI/超声融合前列腺活检中靶向、瘤周与系统穿刺核心产率的比较分析

Perilesional Biopsy in-Systematic Out? Comparative Analysis of Targeted, Perilesional, and Systematic Core Yield by Needle Tracking With Robotic-Assisted Transperineal Magnetic Resonance Imaging/Ultrasound Fusion Prostate Biopsy.
PubMed 文献 · Urology · 2026-10-09

该前瞻性研究分析2020至2024年间566例机器人辅助经会阴MRI/超声融合前列腺活检病例,通过针道追踪精确定位每一条穿刺核心与MRI病灶及前列腺的空间关系。结果显示,在131例临床显著前列腺癌中,6.1%仅由瘤周穿刺检出,系统穿刺额外检出3.8%但仅1.5%来自MRI阴性叶,省略系统穿刺可使GG1过度检出减少24.1%。结论支持采用靶向+瘤周穿刺策略并省略或弱化常规系统穿刺。

要点

  • 瘤周穿刺可有效补充靶向穿刺,提高临床显著前列腺癌检出。
  • 系统穿刺额外检出临床显著癌有限,且增加GG1过度检出。
  • 靶向与瘤周穿刺均阴性时,可考虑省略系统穿刺。

核心结论

  • 瘤周穿刺有效补充靶向活检,系统穿刺额外检出临床显著前列腺癌有限且增加GG1过度检出。
  • 数据支持采用靶向+瘤周穿刺并省略或弱化剩余前列腺的系统穿刺。

研究设计与样本

  • 前瞻性收集2020至2024年间566例机器人辅助经会阴MRI/超声融合前列腺活检病例。
  • 使用iSR'obot Mona Lisa机器人系统,采用靶向+系统或三区(靶向+瘤周+系统)穿刺策略。
  • 瘤周核心定义为距MRI病灶边缘10 mm内的样本,系统核心为靶向-瘤周区域外的样本。
  • 个体化3D前列腺图与逐核心组织病理学关联,临床显著前列腺癌定义为GG≥2。

主要发现

  • 三区队列中131例临床显著前列腺癌,6.1%(8/131)仅由瘤周穿刺检出。
  • 系统穿刺检出靶向和瘤周未捕获的临床显著前列腺癌占3.8%(5/131),仅1.5%(2/131)来自MRI阴性叶。
  • 三区队列中58例GG1过度检出,省略系统穿刺可减少24.1%(14/58)。

临床怎么用

  • 机器人辅助定位支持采用靶向+瘤周穿刺策略,可考虑省略或弱化常规系统穿刺。
  • 靶向和瘤周穿刺均阴性时,省略系统穿刺可减少GG1过度检出。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To characterize prostate cancer (Pca) detection rates by Gleason Grade Group (GG) in targeted, perilesional, and systematic cores sampling the remaining prostate using robotic-assisted transperineal magnetic resonance imaging (MRI) /ultrasound fusion biopsy (RA-TP-FBx), enabling precise spatial documentation of every core relative to MRI-lesions and the prostate. METHODS: We analyzed prospectively collected RA-TP-FBx cases between 2020 and 2024. Biopsies were performed with the iSR'obot Mona Lisa (Biobot). Sampling included a traditional targeted + systematic strategy and a Trizonal approach: targeted + perilesional + systematic. Perilesional cores were defined at biopsy as samples within 10 mm of the MRI-lesion margin and systematic cores as samples outside the targeted-perilesional areas. Individualized 3D prostate maps were correlated with per-core histopathology. Clinically significant PCa (csPCa) was defined as GG ≥ 2. RESULTS: The full cohort included 566 RA-TP-FBx cases. Diagnosis of csPCa (n=131 in the Trizonal cohort) was exclusively due to perilesional sampling in 6.1% (8/131). Systematic biopsy detected csPCa not captured by targeted or perilesional cores in 3.8% (5/131), but only 1.5% (2/131) originated from MRI-negative lobes. Overdetection of GG 1 (n = 58 in the Trizonal cohort) would be reduced by 24.1% (14/58) by omitting systematic cores when targeted and perilesional cores were negative. CONCLUSION: Robotic-assisted mapping demonstrated that perilesional sampling effectively complemented targeted biopsy, while systematic cores yielded minimal additional csPCa detection but increased GG 1 overdetection. These data support adopting targeted + perilesional sampling and omitting or deintensifying the routine addition of systematic cores in the remaining prostate.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Alargkof V, Walter M, Engesser C, et al. Perilesional Biopsy in-Systematic Out? Comparative Analysis of Targeted, Perilesional, and Systematic Core Yield by Needle Tracking With Robotic-Assisted Transperineal Magnetic Resonance Imaging/Ultrasound Fusion Prostate Biopsy. Urology. 2026. PMID: 42854856. doi:10.1016/j.urology.2026.09.065

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。